MXPA06013168A - Apparatus and method for transdermal delivery of parathyroid hormone agents. - Google Patents
Apparatus and method for transdermal delivery of parathyroid hormone agents.Info
- Publication number
- MXPA06013168A MXPA06013168A MXPA06013168A MXPA06013168A MXPA06013168A MX PA06013168 A MXPA06013168 A MX PA06013168A MX PA06013168 A MXPA06013168 A MX PA06013168A MX PA06013168 A MXPA06013168 A MX PA06013168A MX PA06013168 A MXPA06013168 A MX PA06013168A
- Authority
- MX
- Mexico
- Prior art keywords
- transdermal delivery
- parathyroid hormone
- hormone agents
- microprojection member
- epidermis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0046—Solid microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0061—Methods for using microneedles
Abstract
An apparatus and method for transdermally delivering a biologically active agent comprising a delivery system having a microprojection member (or system) that includes a plurality of microprojections (or array thereof) that are adapted to pierce through the stratum corneum into the underlying epidermis layer, or epidermis and dermis layers. In one embodiment, the PTH-based agent is contained in a biocompatible coating that is applied to the microprojection member.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57130404P | 2004-05-13 | 2004-05-13 | |
US58527604P | 2004-07-01 | 2004-07-01 | |
US64366005P | 2005-01-12 | 2005-01-12 | |
PCT/US2005/009147 WO2005112984A2 (en) | 2004-05-13 | 2005-03-18 | Apparatus and method for transdermal delivery of parathyroid hormone agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA06013168A true MXPA06013168A (en) | 2007-05-15 |
Family
ID=35428853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA06013168A MXPA06013168A (en) | 2004-05-13 | 2005-03-18 | Apparatus and method for transdermal delivery of parathyroid hormone agents. |
Country Status (12)
Country | Link |
---|---|
US (4) | US7556821B2 (en) |
EP (1) | EP1744683B1 (en) |
JP (2) | JP5007427B2 (en) |
AR (1) | AR048887A1 (en) |
AU (1) | AU2005244734A1 (en) |
BR (1) | BRPI0509788A (en) |
CA (1) | CA2566032A1 (en) |
ES (1) | ES2568259T3 (en) |
IL (1) | IL179197A0 (en) |
MX (1) | MXPA06013168A (en) |
NO (1) | NO20065720L (en) |
WO (1) | WO2005112984A2 (en) |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6230051B1 (en) * | 1996-06-18 | 2001-05-08 | Alza Corporation | Device for enhancing transdermal agent delivery or sampling |
CN1250171C (en) * | 2000-10-13 | 2006-04-12 | 阿尔扎公司 | Apparatus and method for piercing skin with microtrusions |
US7419481B2 (en) * | 2000-10-13 | 2008-09-02 | Alza Corporation | Apparatus and method for piercing skin with microprotrusions |
ATE428466T1 (en) * | 2000-10-26 | 2009-05-15 | Alza Corp | TRANSDERMAL DRUG DELIVERY SYSTEM WITH COATED MICROPROOFS |
US20020193729A1 (en) * | 2001-04-20 | 2002-12-19 | Cormier Michel J.N. | Microprojection array immunization patch and method |
JP2006500974A (en) * | 2002-06-28 | 2006-01-12 | アルザ・コーポレーシヨン | Transdermal drug delivery device with coated microprojections |
JP4682144B2 (en) | 2003-10-31 | 2011-05-11 | アルザ・コーポレーシヨン | Self-actuating applicator for microprojection arrays |
KR20070011481A (en) * | 2004-04-13 | 2007-01-24 | 알자 코포레이션 | Apparatus and method for transdermal delivery of multiple vaccines |
AU2005244734A1 (en) * | 2004-05-13 | 2005-12-01 | Alza Corporation | Apparatus and method for transdermal delivery of parathyroid hormone agents |
KR20070099540A (en) * | 2004-09-08 | 2007-10-09 | 알자 코포레이션 | Microprojection array with improved skin adhesion and compliance |
CN101267896A (en) * | 2005-09-12 | 2008-09-17 | 阿尔扎公司 | Coatable transdermal delivery microprojection assembly |
CA2628945A1 (en) * | 2005-11-10 | 2007-05-24 | Board Of Control Of Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
WO2007061964A1 (en) * | 2005-11-18 | 2007-05-31 | 3M Innovative Properties Company | Methods for coating microneedles |
AU2006336187A1 (en) * | 2005-12-28 | 2007-07-26 | Alza Corporation | Stable therapeutic formulations |
US9610459B2 (en) | 2009-07-24 | 2017-04-04 | Emkinetics, Inc. | Cooling systems and methods for conductive coils |
US9339641B2 (en) | 2006-01-17 | 2016-05-17 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
AU2007225056A1 (en) * | 2006-03-15 | 2007-09-20 | Alza Corporation | Apparatus and method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia |
US20070293816A1 (en) * | 2006-04-25 | 2007-12-20 | Alza Corporation | Microprojection Array Application with Grouped Microprojections for High Drug Loading |
WO2007127815A2 (en) * | 2006-04-25 | 2007-11-08 | Alza Corporation | Microprojection array application with multilayered microprojection member for high drug loading |
JP2010505471A (en) | 2006-10-02 | 2010-02-25 | エムキネティクス, インコーポレイテッド | Method and apparatus for magnetic induction therapy |
US11224742B2 (en) | 2006-10-02 | 2022-01-18 | Emkinetics, Inc. | Methods and devices for performing electrical stimulation to treat various conditions |
US9005102B2 (en) | 2006-10-02 | 2015-04-14 | Emkinetics, Inc. | Method and apparatus for electrical stimulation therapy |
US10786669B2 (en) | 2006-10-02 | 2020-09-29 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
US8911749B2 (en) | 2007-04-16 | 2014-12-16 | Corium International, Inc. | Vaccine delivery via microneedle arrays |
WO2008130587A2 (en) | 2007-04-16 | 2008-10-30 | Corium International, Inc. | Solvent-cast microneedle arrays containing active |
CN102099475A (en) * | 2008-06-04 | 2011-06-15 | 科达治疗公司 | Treatment of pain with gap junction modulation compounds |
EP2383013A4 (en) * | 2008-12-26 | 2012-11-28 | Hisamitsu Pharmaceutical Co | Microneedle device |
US20100226966A1 (en) * | 2009-03-03 | 2010-09-09 | Daddona Peter E | Method for transdermal controlled release drug delivery |
US20100286600A1 (en) * | 2009-05-08 | 2010-11-11 | Bommannan D Bommi | Transdermal patch device |
EP2493551A4 (en) | 2009-10-26 | 2013-04-17 | Emkinetics Inc | Method and apparatus for electromagnetic stimulation of nerve, muscle, and body tissues |
AU2009356227A1 (en) | 2009-12-07 | 2012-06-21 | Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
WO2011105508A1 (en) | 2010-02-24 | 2011-09-01 | 久光製薬株式会社 | Micro-needle device and preparation method |
AU2011248108B2 (en) * | 2010-05-04 | 2016-05-26 | Corium Pharma Solutions, Inc. | Method and device for transdermal delivery of parathyroid hormone using a microprojection array |
US20130053448A1 (en) | 2010-05-12 | 2013-02-28 | Louis O'Dea | Therapeutic Regimens |
US8588884B2 (en) | 2010-05-28 | 2013-11-19 | Emkinetics, Inc. | Microneedle electrode |
US9133182B2 (en) | 2010-09-28 | 2015-09-15 | Radius Health, Inc. | Selective androgen receptor modulators |
WO2012075375A1 (en) * | 2010-12-02 | 2012-06-07 | Lanco Biosciences, Inc. | Delivery of parathyroid hormones by microinjection systems |
CN103391798A (en) | 2011-02-24 | 2013-11-13 | 久光制药株式会社 | GLP-1 analogue composition for microneedle devices |
JP5695731B2 (en) * | 2011-02-24 | 2015-04-08 | 久光製薬株式会社 | Bioactive nonaqueous composition for microneedle device and bioactive nonaqueous composition attached on microneedle |
JP6033280B2 (en) | 2011-04-22 | 2016-11-30 | ラジウス ヘルス,インコーポレイテッド | Drug delivery method for PTH, PTHrP, and related peptides |
WO2012169435A1 (en) | 2011-06-07 | 2012-12-13 | 旭化成ファーマ株式会社 | Freeze-dried preparation containing high-purity pth and method for producing same |
US10980865B2 (en) | 2012-08-10 | 2021-04-20 | Aquavit Pharmaceuticals, Inc. | Direct application system and method for the delivery of bioactive compositions and formulations |
US9173598B1 (en) * | 2012-08-27 | 2015-11-03 | Abdullah Khalid Al Rasheed | Device for piercing the skin to obtain a blood sample and method of use |
AU2013309944A1 (en) | 2012-08-30 | 2015-03-05 | Medrx Co., Ltd. | Microneedle array coated with drug composition |
CN105073178B (en) | 2012-12-21 | 2019-07-30 | 考里安国际公司 | Microarray and its application method for therapeutic agent delivering |
JP6081215B2 (en) * | 2013-02-13 | 2017-02-15 | 久光製薬株式会社 | Coating and microneedle devices |
ES2692722T3 (en) | 2013-02-13 | 2018-12-04 | Hisamitsu Pharmaceutical Co., Inc. | Microneedle coating composition and microneedle device |
WO2014126105A1 (en) | 2013-02-13 | 2014-08-21 | 久光製薬株式会社 | Microneedle coating composition and microneedle device |
WO2014164314A1 (en) | 2013-03-12 | 2014-10-09 | Corium International, Inc. | Microprojection applicators |
EP2968118B1 (en) | 2013-03-15 | 2022-02-09 | Corium, Inc. | Microarray for delivery of therapeutic agent and methods of use |
WO2014150285A2 (en) | 2013-03-15 | 2014-09-25 | Corium International, Inc. | Multiple impact microprojection applicators and methods of use |
EP2968116A1 (en) | 2013-03-15 | 2016-01-20 | Corium International, Inc. | Microarray with polymer-free microstructures, methods of making, and methods of use |
US20150038897A1 (en) | 2013-07-30 | 2015-02-05 | Zosano Pharma, Inc. | Low-Profile Microneedle Patch Applicator |
JP5728553B2 (en) | 2013-10-18 | 2015-06-03 | ユニ・チャーム株式会社 | Non-woven fabric bulk recovery device and non-woven fabric bulk recovery method |
JP5728552B2 (en) | 2013-10-18 | 2015-06-03 | ユニ・チャーム株式会社 | Non-woven fabric bulk recovery device and non-woven fabric bulk recovery method |
US10624843B2 (en) | 2014-09-04 | 2020-04-21 | Corium, Inc. | Microstructure array, methods of making, and methods of use |
WO2016081616A2 (en) * | 2014-11-18 | 2016-05-26 | 4P Therapeutics | Transdermal patch formulations for delivery of water soluble drugs, peptides, proteins and oligosaccharides |
US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9375478B1 (en) | 2015-01-30 | 2016-06-28 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
EP4039253A1 (en) | 2015-04-29 | 2022-08-10 | Radius Pharmaceuticals, Inc. | Methods of treating cancer |
WO2017004067A1 (en) | 2015-06-29 | 2017-01-05 | Corium International, Inc. | Microarray for delivery of therapeutic agent, methods of use, and methods of making |
JP7116680B2 (en) * | 2015-10-09 | 2022-08-10 | キンデーバ ドラッグ デリバリー リミティド パートナーシップ | Zinc composition for coated microneedle arrays |
AU2017217609B2 (en) | 2016-02-08 | 2023-03-09 | Lunaphore Technologies Sa | Methods of sample cycle multiplexing and in situ imaging |
WO2017143345A1 (en) | 2016-02-19 | 2017-08-24 | Zp Opco, Inc. | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines |
EP3998061A1 (en) | 2016-04-18 | 2022-05-18 | Radius Health, Inc. | Formulations of abaloparatide, transdermal patches thereof, and uses thereof |
WO2017223115A1 (en) | 2016-06-22 | 2017-12-28 | Radius Health, Inc. | Ar+ breast cancer treatment methods |
EP3565542B1 (en) | 2017-01-05 | 2024-04-10 | Radius Pharmaceuticals, Inc. | Polymorphic forms of rad1901-2hcl |
KR20210155817A (en) | 2017-08-23 | 2021-12-23 | 조사노 파마 코포레이션 | Method of rapidly achieving therapeutic concentrations of zolmitriptan for treatment of migraines and cluster headaches |
US11660264B2 (en) | 2017-08-23 | 2023-05-30 | Emergex USA Corporation | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches |
JP6577683B2 (en) * | 2017-09-22 | 2019-09-18 | 旭化成ファーマ株式会社 | Liquid pharmaceutical composition containing teriparatide having excellent stability |
US11660265B2 (en) | 2018-06-28 | 2023-05-30 | Emergex USA Corporation | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches |
JP7473486B2 (en) | 2018-07-04 | 2024-04-23 | ラジウス ファーマシューティカルズ,インコーポレイテッド | Polymorphic forms of RAD1901-2HCL |
Family Cites Families (120)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3123212A (en) | 1964-03-03 | Multiple disposable intracutaneous injector package | ||
USRE25637E (en) | 1964-09-08 | Means for vaccinating | ||
US2619962A (en) | 1948-02-19 | 1952-12-02 | Res Foundation | Vaccination appliance |
US2893392A (en) | 1958-01-08 | 1959-07-07 | American Cyanamid Co | Article of manufacture for intracutaneous injections |
US3072122A (en) | 1959-01-15 | 1963-01-08 | Rosenthal Sol Roy | Package for transcutaneous injection |
US3221739A (en) | 1962-03-26 | 1965-12-07 | Rosenthal Sol Roy | Injection device |
US3221740A (en) | 1962-08-31 | 1965-12-07 | Rosenthal Sol Roy | Injection device |
US3964482A (en) | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
US3678150A (en) | 1971-07-27 | 1972-07-18 | American Cyanamid Co | Process for improving the stability of ppd, qt and histoplasmin on tine applicators |
BE795384A (en) | 1972-02-14 | 1973-08-13 | Ici Ltd | DRESSINGS |
US4086196A (en) | 1975-03-28 | 1978-04-25 | Armour Pharmaceutical Company | Parathyroid hormone |
IL78342A (en) | 1985-04-04 | 1991-06-10 | Gen Hospital Corp | Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof |
SE8501990D0 (en) | 1985-04-24 | 1985-04-24 | Pharmacia Ab | BELEGGNINGSFORFARANDE |
US5420242A (en) | 1986-10-22 | 1995-05-30 | Kaare M. Gautvik | Production of human parathyroid hormone from microorganisms |
US4833125A (en) | 1986-12-05 | 1989-05-23 | The General Hospital Corporation | Method of increasing bone mass |
US5080646A (en) | 1988-10-03 | 1992-01-14 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
KR970008118B1 (en) | 1987-07-09 | 1997-05-21 | 엘테에스 로오만 테라피-지스테메 게엠베하 운트 콤파니 카게 | Transdermal therapeutic system |
US5527772A (en) | 1987-10-20 | 1996-06-18 | Holick; Michael F. | Regulation of cell proliferation and differentiation using peptides |
US5147296A (en) | 1988-10-03 | 1992-09-15 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
US5169382A (en) | 1988-10-03 | 1992-12-08 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
EP0429842B1 (en) | 1989-10-27 | 1996-08-28 | Korea Research Institute Of Chemical Technology | Device for the transdermal administration of protein or peptide drug |
US5279544A (en) | 1990-12-13 | 1994-01-18 | Sil Medics Ltd. | Transdermal or interdermal drug delivery devices |
US5208041A (en) | 1991-05-23 | 1993-05-04 | Allelix Biopharmaceuticals Inc. | Essentially pure human parathyroid hormone |
US5563122A (en) | 1991-12-09 | 1996-10-08 | Asahi Kasei Kogyo Kabushiki Kaisha | Stabilized parathyroid hormone composition |
US5629019A (en) * | 1992-02-27 | 1997-05-13 | Alza Corporation | Formulations with hydrophobic permeation enhancers |
US5225098A (en) * | 1992-03-20 | 1993-07-06 | The Procter & Gamble Company | Neutral pH freezer bar and process |
US5382658A (en) | 1992-04-03 | 1995-01-17 | Allelix Biopharmaceuticals Inc. | Stability-enhanced variants of parathyroid hormone |
AU672790B2 (en) | 1992-07-15 | 1996-10-17 | Novartis Ag | Variants of parathyroid hormone and its fragments |
IT1255723B (en) | 1992-10-09 | 1995-11-13 | USE OF PARATORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS AND RELATED PEPTIDES, FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION AND THERAPY OF ABORTION AND PRETERMONE BIRTH AND IN GENERAL FOR THE TREATMENT OF GESTATION | |
CA2153681C (en) * | 1993-01-21 | 2004-05-25 | Marc Karel Jozef Francois | Topical ketoconazole compositions |
JP3628713B2 (en) * | 1993-06-07 | 2005-03-16 | 帝國製薬株式会社 | Vaginal preparation containing physiologically active peptide |
TW303299B (en) | 1993-07-22 | 1997-04-21 | Lilly Co Eli | |
US5679647A (en) * | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
DE4341444C2 (en) | 1993-12-04 | 1996-03-14 | Lohmann Therapie Syst Lts | Active substance-containing plaster and process for its production |
US5496801A (en) | 1993-12-23 | 1996-03-05 | Allelix Biopharmaceuticals Inc. | Parathyroid hormone formulation |
US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
WO1996014822A1 (en) * | 1994-11-15 | 1996-05-23 | Osmotics Corporation | Skin care compositions and methods |
US5747456A (en) | 1994-12-19 | 1998-05-05 | Beth Israel Deaconess Medical Center | Continuous low-dose administration of parathyroid hormone or its agonist |
WO1996021706A1 (en) | 1995-01-14 | 1996-07-18 | Jochen Daume | Heat-transfer concentrate, method of manufacturing it and its use, as well as a latent-heat accumulator making use of the concentrate |
US5550134A (en) | 1995-05-10 | 1996-08-27 | Eli Lilly And Company | Methods for inhibiting bone loss |
AU5740496A (en) | 1995-05-22 | 1996-12-11 | General Hospital Corporation, The | Micromechanical device and method for enhancing delivery of compounds through the skin |
WO1996037256A1 (en) | 1995-05-22 | 1996-11-28 | Silicon Microdevices, Inc. | Micromechanical patch for enhancing the delivery of compounds through the skin |
US5599822A (en) | 1995-06-06 | 1997-02-04 | Eli Lilly And Company | Methods for minimizing bone loss |
EP0878201B1 (en) | 1996-02-01 | 2002-06-19 | Chugai Seiyaku Kabushiki Kaisha | Medicaments for the treatment or prevention of thrombocytopenia |
US5935607A (en) | 1996-02-15 | 1999-08-10 | Hadasit Medical Research Services And Development Company Ltd. | Treatment of osteoporosis |
US6230051B1 (en) | 1996-06-18 | 2001-05-08 | Alza Corporation | Device for enhancing transdermal agent delivery or sampling |
US5738728A (en) | 1996-07-26 | 1998-04-14 | Bio Dot, Inc. | Precision metered aerosol dispensing apparatus |
US5743960A (en) | 1996-07-26 | 1998-04-28 | Bio-Dot, Inc. | Precision metered solenoid valve dispenser |
US5741554A (en) | 1996-07-26 | 1998-04-21 | Bio Dot, Inc. | Method of dispensing a liquid reagent |
US5916524A (en) | 1997-07-23 | 1999-06-29 | Bio-Dot, Inc. | Dispensing apparatus having improved dynamic range |
EP0917537B1 (en) | 1996-07-31 | 2005-09-07 | The General Hospital Corporation | Novel parathyroid hormone-related peptide analogs |
US5983136A (en) | 1996-09-17 | 1999-11-09 | Deka Products Limited Partnership | System for delivery of drugs by transport |
AU6883398A (en) | 1997-04-03 | 1998-10-22 | Eli Lilly And Company | Methods of treating bone loss |
IL120943A (en) | 1997-05-29 | 2004-03-28 | Univ Ben Gurion | Transdermal delivery system |
JP2001519384A (en) | 1997-10-14 | 2001-10-23 | イーライ・リリー・アンド・カンパニー | Methods for building and maintaining bone |
US6770623B1 (en) | 1997-12-09 | 2004-08-03 | Eli Lilly And Company | Stabilized teriparatide solutions |
US6918901B1 (en) | 1997-12-10 | 2005-07-19 | Felix Theeuwes | Device and method for enhancing transdermal agent flux |
DK1037686T3 (en) | 1997-12-11 | 2006-01-02 | Alza Corp | Apparatus for enhancing transdermal flow of agents |
ATE221400T1 (en) | 1997-12-11 | 2002-08-15 | Alza Corp | DEVICE FOR INCREASE THE TRANSDERMAL FLOW OF ACTIVE INGREDIENTS |
JP2001525227A (en) | 1997-12-11 | 2001-12-11 | アルザ・コーポレーション | Device for increasing transdermal drug flow |
EP0922467A3 (en) * | 1997-12-12 | 2000-05-24 | Takeda Chemical Industries, Ltd. | Iontophoretic drug delivery |
BR9813740A (en) | 1997-12-18 | 2000-10-10 | Lilly Co Eli | Crystalline teriparatide |
US6091975A (en) | 1998-04-01 | 2000-07-18 | Alza Corporation | Minimally invasive detecting device |
DZ2873A1 (en) | 1998-08-19 | 2003-12-15 | Lilly Co Eli | Method for increasing bone hardness and stiffness. |
US20040033950A1 (en) | 2000-09-26 | 2004-02-19 | Hock Janet M. | Method of increasing bone toughness and stiffness and reducing fractures |
EP1109594B1 (en) * | 1998-08-31 | 2004-10-27 | Johnson & Johnson Consumer Companies, Inc. | Electrotransport device comprising blades |
CA2245903A1 (en) | 1998-09-28 | 2000-03-28 | Mcgill University | Use of pex in the treatment of metabolic bone diseases |
CA2346695A1 (en) | 1998-10-07 | 2000-04-13 | The Board Of Trustees Of The University Of Arkansas | Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof |
US6537965B1 (en) * | 1998-11-25 | 2003-03-25 | The General Hospital Corporation | Amino-terminal modified parathyroid hormone (PTH) analogs |
US6884427B1 (en) | 1999-02-08 | 2005-04-26 | Aderans Research Institute, Inc. | Filamentary means for introducing agents into tissue of a living host |
US6743211B1 (en) | 1999-11-23 | 2004-06-01 | Georgia Tech Research Corporation | Devices and methods for enhanced microneedle penetration of biological barriers |
US6379324B1 (en) | 1999-06-09 | 2002-04-30 | The Procter & Gamble Company | Intracutaneous microneedle array apparatus |
US6256533B1 (en) | 1999-06-09 | 2001-07-03 | The Procter & Gamble Company | Apparatus and method for using an intracutaneous microneedle array |
WO2001022093A1 (en) | 1999-09-20 | 2001-03-29 | Eli Lilly And Company | Method for monitoring treatment with a parathyroid hormone |
WO2001021198A1 (en) | 1999-09-20 | 2001-03-29 | Eli Lilly And Company | Method for reducing the risk of cancer |
US6623457B1 (en) | 1999-09-22 | 2003-09-23 | Becton, Dickinson And Company | Method and apparatus for the transdermal administration of a substance |
US6835184B1 (en) | 1999-09-24 | 2004-12-28 | Becton, Dickinson And Company | Method and device for abrading skin |
US20020095134A1 (en) | 1999-10-14 | 2002-07-18 | Pettis Ronald J. | Method for altering drug pharmacokinetics based on medical delivery platform |
US8465468B1 (en) * | 2000-06-29 | 2013-06-18 | Becton, Dickinson And Company | Intradermal delivery of substances |
KR100452972B1 (en) * | 2000-05-16 | 2004-10-14 | 주식회사 삼양사 | Hydrogel composition for transdermal drug |
US6565532B1 (en) | 2000-07-12 | 2003-05-20 | The Procter & Gamble Company | Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup |
US6537242B1 (en) | 2000-06-06 | 2003-03-25 | Becton, Dickinson And Company | Method and apparatus for enhancing penetration of a member for the intradermal sampling or administration of a substance |
US20050008683A1 (en) | 2000-06-29 | 2005-01-13 | Becton Dickinson And Company | Method for delivering interferons to the intradermal compartment |
US6589202B1 (en) | 2000-06-29 | 2003-07-08 | Becton Dickinson And Company | Method and apparatus for transdermally sampling or administering a substance to a patient |
US6440096B1 (en) | 2000-07-14 | 2002-08-27 | Becton, Dickinson And Co. | Microdevice and method of manufacturing a microdevice |
GB0017999D0 (en) | 2000-07-21 | 2000-09-13 | Smithkline Beecham Biolog | Novel device |
JP4198985B2 (en) | 2000-10-13 | 2008-12-17 | アルザ・コーポレーシヨン | Microblade array impact applicator. |
CN1250171C (en) | 2000-10-13 | 2006-04-12 | 阿尔扎公司 | Apparatus and method for piercing skin with microtrusions |
MXPA03003303A (en) | 2000-10-13 | 2004-12-13 | Johnson & Johnson | Microprotrusion member retainer for impact applicator. |
ATE428466T1 (en) * | 2000-10-26 | 2009-05-15 | Alza Corp | TRANSDERMAL DRUG DELIVERY SYSTEM WITH COATED MICROPROOFS |
US9302903B2 (en) | 2000-12-14 | 2016-04-05 | Georgia Tech Research Corporation | Microneedle devices and production thereof |
WO2002074173A1 (en) * | 2001-03-16 | 2002-09-26 | Alza Corporation | Method and apparatus for coating skin piercing microprojections |
US20020193729A1 (en) | 2001-04-20 | 2002-12-19 | Cormier Michel J.N. | Microprojection array immunization patch and method |
MXPA03009603A (en) * | 2001-04-20 | 2004-12-06 | Johnson & Johnson | Microprojection array having a beneficial agent containing coating. |
US6881203B2 (en) | 2001-09-05 | 2005-04-19 | 3M Innovative Properties Company | Microneedle arrays and methods of manufacturing the same |
WO2003026733A2 (en) | 2001-09-28 | 2003-04-03 | Biovalve Technologies, Inc. | Microneedle with membrane |
US6689100B2 (en) | 2001-10-05 | 2004-02-10 | Becton, Dickinson And Company | Microdevice and method of delivering or withdrawing a substance through the skin of an animal |
US20040242489A1 (en) | 2001-11-05 | 2004-12-02 | Mitlak Bruce Howard | Method for improving stability of a bone-connecting implant |
EP1485317A2 (en) | 2001-11-30 | 2004-12-15 | Alza Corporation | Methods and apparatuses for forming microprojection arrays |
DE60223844T2 (en) | 2001-12-20 | 2008-08-28 | Alza Corp., Mountain View | MICROPROPERTIES FOR THROUGHPING THE SKIN WITH PILLAR DEPTH CONTROL |
US7015262B2 (en) | 2002-05-01 | 2006-03-21 | Lifescan, Inc. | Hydrophilic coatings for medical implements |
EP1513547A4 (en) | 2002-05-23 | 2009-11-04 | Michael F Holick | Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy |
JP2006500974A (en) | 2002-06-28 | 2006-01-12 | アルザ・コーポレーシヨン | Transdermal drug delivery device with coated microprojections |
US20040115167A1 (en) * | 2002-09-30 | 2004-06-17 | Michel Cormier | Drug delivery device and method having coated microprojections incorporating vasoconstrictors |
AR042815A1 (en) | 2002-12-26 | 2005-07-06 | Alza Corp | ACTIVE AGENT SUPPLY DEVICE THAT HAS COMPOUND MEMBERS |
US20050123507A1 (en) * | 2003-06-30 | 2005-06-09 | Mahmoud Ameri | Formulations for coated microprojections having controlled solubility |
ATE369802T1 (en) * | 2003-06-30 | 2007-09-15 | Alza Corp | METHOD FOR COATING MICROPROJECTIONS FOR PIERCING THE SKIN |
CA2530531A1 (en) | 2003-06-30 | 2005-01-20 | Alza Corporation | Formulations for coated microprojections containing non-volatile counterions |
ATE509207T1 (en) * | 2003-07-10 | 2011-05-15 | Skf Ab | BEARING UNIT WITH SOLDER OR HARD SOLDER CONNECTION |
AU2004257362A1 (en) | 2003-07-15 | 2005-01-27 | National Research Council Of Canada | Cyclic analogs of human parathyroid hormone for the treatment of conditions characterized by hyperproliferative skin cells |
US20050049549A1 (en) * | 2003-08-04 | 2005-03-03 | Wong Patrick S.L. | Method and device for enhancing transdermal agent flux |
JP2007508914A (en) * | 2003-10-24 | 2007-04-12 | アルザ・コーポレーシヨン | Apparatus and method for facilitating transdermal drug delivery |
AU2004287059A1 (en) * | 2003-10-28 | 2005-05-19 | Alza Corporation | Delivery of polymer conjugates of therapeutic peptides and proteins via coated microporjections |
JP4682144B2 (en) | 2003-10-31 | 2011-05-11 | アルザ・コーポレーシヨン | Self-actuating applicator for microprojection arrays |
EP1682012A4 (en) * | 2003-11-13 | 2008-09-24 | Alza Corp | Composition and apparatus for transdermal delivery |
EP1557176A1 (en) | 2004-01-26 | 2005-07-27 | Ferring B.V. | Treatment of bone metastases by means of PTH receptor agonists |
AU2005244734A1 (en) * | 2004-05-13 | 2005-12-01 | Alza Corporation | Apparatus and method for transdermal delivery of parathyroid hormone agents |
AU2005260834A1 (en) | 2004-07-14 | 2006-01-19 | Chugai Seiyaku Kabushiki Kaisha | PTH-containing preparation for transmucosal administration |
AU2005304687B2 (en) | 2004-11-11 | 2012-01-19 | The General Hosptial Corporation | Parathyroid hormone receptor activation and stem and progenitor cell expansion |
CN101151061B (en) | 2005-01-31 | 2011-05-25 | 阿尔扎公司 | Coated microprojections having reduced variability and method for producing same |
-
2005
- 2005-03-18 AU AU2005244734A patent/AU2005244734A1/en not_active Abandoned
- 2005-03-18 ES ES05727716.2T patent/ES2568259T3/en active Active
- 2005-03-18 CA CA002566032A patent/CA2566032A1/en not_active Abandoned
- 2005-03-18 JP JP2007513130A patent/JP5007427B2/en not_active Expired - Fee Related
- 2005-03-18 MX MXPA06013168A patent/MXPA06013168A/en unknown
- 2005-03-18 BR BRPI0509788-6A patent/BRPI0509788A/en not_active IP Right Cessation
- 2005-03-18 EP EP05727716.2A patent/EP1744683B1/en active Active
- 2005-03-18 WO PCT/US2005/009147 patent/WO2005112984A2/en active Application Filing
- 2005-03-18 US US11/084,634 patent/US7556821B2/en active Active
- 2005-05-05 AR ARP050101822A patent/AR048887A1/en not_active Application Discontinuation
-
2006
- 2006-11-12 IL IL179197A patent/IL179197A0/en unknown
- 2006-12-12 NO NO20065720A patent/NO20065720L/en not_active Application Discontinuation
-
2009
- 2009-06-08 US US12/455,830 patent/US9295714B2/en active Active
- 2009-07-01 US US12/459,499 patent/US8361022B2/en active Active
-
2010
- 2010-03-02 US US12/716,184 patent/US8633159B2/en active Active
-
2011
- 2011-11-25 JP JP2011258227A patent/JP5309203B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
BRPI0509788A (en) | 2007-10-23 |
EP1744683A4 (en) | 2010-09-29 |
JP5007427B2 (en) | 2012-08-22 |
AR048887A1 (en) | 2006-06-07 |
NO20065720L (en) | 2007-02-13 |
US8633159B2 (en) | 2014-01-21 |
WO2005112984A3 (en) | 2006-04-20 |
US20100119568A1 (en) | 2010-05-13 |
JP5309203B2 (en) | 2013-10-09 |
AU2005244734A1 (en) | 2005-12-01 |
US20100160895A1 (en) | 2010-06-24 |
EP1744683B1 (en) | 2016-03-16 |
IL179197A0 (en) | 2007-03-08 |
US7556821B2 (en) | 2009-07-07 |
US8361022B2 (en) | 2013-01-29 |
CA2566032A1 (en) | 2005-12-01 |
WO2005112984A2 (en) | 2005-12-01 |
US20100152649A1 (en) | 2010-06-17 |
ES2568259T3 (en) | 2016-04-28 |
JP2012097087A (en) | 2012-05-24 |
US20050256045A1 (en) | 2005-11-17 |
JP2007536988A (en) | 2007-12-20 |
EP1744683A2 (en) | 2007-01-24 |
US9295714B2 (en) | 2016-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA06013168A (en) | Apparatus and method for transdermal delivery of parathyroid hormone agents. | |
EP2001453A4 (en) | Apparatus and method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia | |
TW200602099A (en) | Apparatus and method for transdermal delivery of fentanyl-based agents | |
TW200600132A (en) | Frequency assisted transdermal agent delivery method and system | |
TW200616660A (en) | Apparatus and method for transdermal delivery of natriuretic peptides | |
WO2005099751A3 (en) | Apparatus and method for transdermal delivery of influenza vaccine | |
TW200618830A (en) | Micorprojection apparatus and system with low infection potential | |
TW200600107A (en) | Apparatus and method for transdermal delivery of multiple vaccines | |
WO2005051455A3 (en) | Ultrasound assisted transdermal vaccine delivery method and system | |
TW200502017A (en) | Active agent delivery device having composite members | |
TW200517156A (en) | Pretreatment method and system for enhancing transdermal drug delivery | |
TW200621316A (en) | Apparatus and method for transdermal delivery of vascular endothelial growth factors | |
MXPA03003815A (en) | Transdermal drug delivery devices having coated microprotrusions. | |
WO2004030743A3 (en) | Drug delivery device having coated microprojections incorporating vasoconstrictors | |
WO2004105729A3 (en) | Transdermal vaccine delivery device having coated microprotrusions | |
TW200613029A (en) | System and method for drug delivery and microfluidic applications using microneedles | |
AR047229A1 (en) | ADMINISTRATION OF POLYMERIC CONJUGATES OF PEPTIDES AND THERAPEUTIC PROTEINS BY MEANS OF COVERED MICROPROJECTIONS | |
WO2007011788A3 (en) | Skin penetrating device and method of use | |
JP2006525316A5 (en) | ||
TW200605929A (en) | Method and apparatus for reducing the incidence of tobacco use | |
TW200738252A (en) | Apparatus and method for transdermal delivery of Epoetin-based agents | |
CA2569285A1 (en) | Methods of device-assisted drug delivery | |
TW200602019A (en) | Apparatus and method for transdermal delivery of parathyroid hormone agents | |
WO2006113796A3 (en) | Microbial cellulose materials for use in transdermal drug delivery system | |
KR20190127235A (en) | Needle patch having improved delivery of cosmetic solution |